| |
| |
|
| Insider
Information: |
Gutman Arie |
| Relationship: |
Former director and of... |
| City: |
Spring Valley |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
120 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
120 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
Former director and of... |
2006-01-31 |
120 |
2004-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRX |
Par Pharmaceutical Compan... |
Former director and officer |
– – – |
2006-01-31 |
4 |
S |
$32.70 |
$181,373 |
D/D |
(5,535) |
120 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
officerTitle |
– – – |
2006-01-26 |
4 |
S |
$31.60 |
$211,720 |
D/D |
(6,700) |
0 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
officerTitle |
– – – |
2006-01-26 |
4 |
OE |
$21.65 |
$145,055 |
D/D |
6,700 |
6,700 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Former Director & Officer |
– – – |
2006-01-25 |
4 |
S |
$31.83 |
$1,909,800 |
D/D |
(60,000) |
0 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Former Director & Officer |
– – – |
2006-01-25 |
4 |
OE |
$21.65 |
$1,299,000 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Former Director & Officer |
– – – |
2006-01-24 |
4 |
S |
$32.12 |
$748,396 |
D/D |
(23,300) |
0 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Former Director & Officer |
– – – |
2006-01-24 |
4 |
OE |
$21.65 |
$504,445 |
D/D |
23,300 |
23,300 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Former Director & Officer |
– – – |
2006-01-23 |
4 |
OE |
$21.65 |
$1,299,000 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Former Director & Officer |
– – – |
2006-01-23 |
4 |
S |
$32.20 |
$1,932,000 |
D/D |
(60,000) |
0 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres. FineTech Laboratories |
– • – |
2005-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,655 |
5,655 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres-Fine Tech Laboratories |
– • – |
2004-12-23 |
4 |
S |
$42.00 |
$844,018 |
D/D |
(20,000) |
0 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres-Fine Tech Laboratories |
– • – |
2004-12-23 |
4 |
OE |
$21.65 |
$433,000 |
D/D |
20,000 |
20,000 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres-FineTech Laboratories Ltd |
– • – |
2004-09-21 |
4/A |
S |
$37.80 |
$1,283,800 |
D/D |
(33,500) |
0 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres-FineTech Laboratories Ltd |
– • – |
2004-09-21 |
4/A |
S |
$38.84 |
$58,260 |
D/D |
(1,500) |
10,000 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres-FineTech Laboratories Ltd |
– • – |
2004-09-21 |
4/A |
OE |
$21.65 |
$757,750 |
D/D |
35,000 |
35,000 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres-FineTech Laboratories Ltd |
– • – |
2004-09-17 |
4 |
S |
$41.50 |
$830,020 |
D/D |
(20,000) |
0 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres-FineTech Laboratories Ltd |
– • – |
2004-09-17 |
4 |
OE |
$21.65 |
$433,000 |
D/D |
20,000 |
20,000 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
